“…On the other hand, BPC 157 was proved to be efficacious in the ulcerative colitis, both in clinical settings [ 71 , 72 ] as well as in experimental rat model ischemic/reperfusion vascular ulcerative colitis studies [ 34 ]. Furthermore, it has been shown to be efficacious in other ulcerative colitis models, including models induced by TNBS, cysteamine, surgery, NSAIDs [ 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 ] or major vessel occlusion [ 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 ]; these studies have included various species [ 81 , 82 ], and complications (for review see, i.e., [ 83 ]). A particular point for revealing and applying the concept of the counteraction of the isoprenaline-induced myocardial infarction in practice may be BPC 157′s beneficial effect on a larger range of arrhythmias in addition to vessel occlusion-induced arrhythmias [ 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 ] (i.e., digitalis [ 8 ]-, neuroleptics [ 9 ]-, succinylcholine [ 7 ]-, potassium over-dose [ 6 ]-, lithium over-dose [ 22 ]-, bupivacaine [ 10 ]-, and lidocaine [ 11 ]- induced arrhythmias).…”